{"title":"对使用血管通路装置的311例金黄色葡萄球菌菌血症的回顾性研究:2008-2018年新西兰怀卡托地区的发病率","authors":"Lynette Lennox, Jenny Heretini","doi":"10.5455/jmid.2023.v13.i2.1","DOIUrl":null,"url":null,"abstract":"Aim: To document retrospectively whether New Zealand (NZ) Māori have a higher incidence of health associated (HA)staphylococcus aureus bacteraemia (SAB) with a vascular-access-device (VAD) compared to other ethnicities in Waikato District Health Board (WDHB). Methods: From the 1 January 2008 to 31 December 2018, all ages of inpatients with a VAD HA-SAB in one District Health Board (DHB) were retrospectively studied. All data was obtained from the Infection Prevention and Control (IPC) SAB records and analysed. Results: The study period of eleven years identified 311 VAD HA-SABs. The overall statistical hypothesis testing of VAD HA-SABs were P=0.175. A greater proportion of VAD HA-SABs occurred in the renal population at a rate of 35.7% (111). Renal representation of ethnic groups with a VAD HA-SAB were Non-NZ Māori 52.86% and Māori 47.14%. Peripheral VAD had greater percentage of incidence of VAD HA-SAB. Conclusions: Māori renal patients with VAD’s in WDHB experienced increased incidence of HA-SABs from 2008-2018 in comparison to other ethnic populations. Māori renal patients are 3 ½ times more likely to suffer VAD HA-SAB than Non-Māori patients. NZ data for VAD HA-SABS requires IPC teams to include ethnicity and provide a standardised, correct diagnosis of a VAD HA-SABS. NZ health strategies need to ask well directed questions in order to progress toward equitable health outcomes.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"98 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Retrospective study of 311 cases of Staphylococcus aureus bacteraemia with vascular access devices compared to ethnicity: Incidence in Waikato New Zealand from 2008-2018\",\"authors\":\"Lynette Lennox, Jenny Heretini\",\"doi\":\"10.5455/jmid.2023.v13.i2.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: To document retrospectively whether New Zealand (NZ) Māori have a higher incidence of health associated (HA)staphylococcus aureus bacteraemia (SAB) with a vascular-access-device (VAD) compared to other ethnicities in Waikato District Health Board (WDHB). Methods: From the 1 January 2008 to 31 December 2018, all ages of inpatients with a VAD HA-SAB in one District Health Board (DHB) were retrospectively studied. All data was obtained from the Infection Prevention and Control (IPC) SAB records and analysed. Results: The study period of eleven years identified 311 VAD HA-SABs. The overall statistical hypothesis testing of VAD HA-SABs were P=0.175. A greater proportion of VAD HA-SABs occurred in the renal population at a rate of 35.7% (111). Renal representation of ethnic groups with a VAD HA-SAB were Non-NZ Māori 52.86% and Māori 47.14%. Peripheral VAD had greater percentage of incidence of VAD HA-SAB. Conclusions: Māori renal patients with VAD’s in WDHB experienced increased incidence of HA-SABs from 2008-2018 in comparison to other ethnic populations. Māori renal patients are 3 ½ times more likely to suffer VAD HA-SAB than Non-Māori patients. NZ data for VAD HA-SABS requires IPC teams to include ethnicity and provide a standardised, correct diagnosis of a VAD HA-SABS. NZ health strategies need to ask well directed questions in order to progress toward equitable health outcomes.\",\"PeriodicalId\":16603,\"journal\":{\"name\":\"Journal of Microbiology and Infectious Diseases\",\"volume\":\"98 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Microbiology and Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5455/jmid.2023.v13.i2.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Microbiology and Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/jmid.2023.v13.i2.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Retrospective study of 311 cases of Staphylococcus aureus bacteraemia with vascular access devices compared to ethnicity: Incidence in Waikato New Zealand from 2008-2018
Aim: To document retrospectively whether New Zealand (NZ) Māori have a higher incidence of health associated (HA)staphylococcus aureus bacteraemia (SAB) with a vascular-access-device (VAD) compared to other ethnicities in Waikato District Health Board (WDHB). Methods: From the 1 January 2008 to 31 December 2018, all ages of inpatients with a VAD HA-SAB in one District Health Board (DHB) were retrospectively studied. All data was obtained from the Infection Prevention and Control (IPC) SAB records and analysed. Results: The study period of eleven years identified 311 VAD HA-SABs. The overall statistical hypothesis testing of VAD HA-SABs were P=0.175. A greater proportion of VAD HA-SABs occurred in the renal population at a rate of 35.7% (111). Renal representation of ethnic groups with a VAD HA-SAB were Non-NZ Māori 52.86% and Māori 47.14%. Peripheral VAD had greater percentage of incidence of VAD HA-SAB. Conclusions: Māori renal patients with VAD’s in WDHB experienced increased incidence of HA-SABs from 2008-2018 in comparison to other ethnic populations. Māori renal patients are 3 ½ times more likely to suffer VAD HA-SAB than Non-Māori patients. NZ data for VAD HA-SABS requires IPC teams to include ethnicity and provide a standardised, correct diagnosis of a VAD HA-SABS. NZ health strategies need to ask well directed questions in order to progress toward equitable health outcomes.